68 unknown. 68 Phase 2, 17 Phase 3, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 68 | Unknown 68 |
| Phase 3 | 17 | Unknown 17 |
| Phase 1 | 6 | Unknown 6 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Capital Medical University | 302 | 2024-11-20 | 2024-10-29 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute | Phase 2 | Unknown | Yongjun Wang | 100 | 2024-08-04 | 2024-08-12 |
| European Blood Pressure Intensive Control After Stroke anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration, Standard of Care Blood Pressure Management with Antihypertensives - Ischemic Stroke, Transient Ischemic Attack | Phase 2 | Unknown | University College Dublin | 142 | 2024-05-02 | 2024-07-11 |
| BXOS110 Injection in the Treatment of Acute Ischaemic Stroke high-dose BXOS110, low-dose BXOS110, Placebo - Acute Ischemic Stroke | Phase 2 | Unknown | Biocells (Beijing) Biotech Co.,Ltd | 300 | 2024-02-07 | 2024-03-21 |
| Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis Rivaroxaban, Clopidogrel, Aspirin - Ischemic Stroke, Intracranial Atherosclerosis | Phase 2 / Phase 3 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 1180 | 2023-12-30 | 2023-12-21 |
| Phase 2 Study of TXA127 in Post-ischemic Stroke Patients talfirastide, Placebo - Ischemic Stroke | Phase 2 | Unknown | Constant Therapeutics LLC | 50 | 2023-11-26 | 2023-12-21 |
| EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual tablets, Low-dose Cilostazol - Acute Ischemic Stroke, Large Vessel Occlusion | Phase 2 | Unknown | Beijing Tiantan Hospital | 300 | 2023-11-01 | 2023-11-18 |
| COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE) Colchicine 0.5 MG - Ischemic Stroke, Atherosclerosis | Phase 2 | Unknown | University College Dublin | 91 | 2023-10-01 | 2023-10-02 |
| RCT of Ghrelin in Stroke Patients Ghrelin - Stroke, Ischemic | Phase 2 | Unknown | Rijnstate Hospital | 80 | 2023-10-01 | 2023-07-25 |
| Sodium Valproate in Patients With Acute Ischemic Stroke Sodium valproate, Normal saline - Acute Ischemic Stroke | Phase 2 | Unknown | RenJi Hospital | 40 | 2023-09-01 | 2024-02-21 |
| Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion Y-6 sublingual tablets, Placebo tablets of Y-6 sublingual tablet - Acute Ischemic Stroke, Reperfusion | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-06-05 | 2023-09-28 |
| Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization Hypotensive Drugs and/or Vasoactive Drugs - Ischemic Stroke, Revascularization | Phase 2 | Unknown | Beijing Tiantan Hospital | 100 | 2023-06-04 | 2023-01-05 |
| Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Sarecycline Tablet, Placebo tablets of Sarecycline tablets - Ischemic Stroke, Acute | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-05-07 | 2023-07-20 |
| NanO2 for Large Vessel Occlusion Stroke Placebo, dodecafluoropentane emulsion (DDFPe) - Ischemic Stroke | Phase 2 / Phase 3 | Unknown | NuvOx LLC | 300 | 2023-04-01 | 2022-05-25 |
| Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke The KPCXM18 injection, Placebo - Acute Ischemic Stroke | Phase 2 | Unknown | Kunming Pharmaceuticals, Inc. | 240 | 2023-03-01 | 2023-02-28 |
| Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Dengzhanxixin Injection, Placebo injection - Acute Ischemic Stroke | Phase 2 | Unknown | Beijing Tiantan Hospital | 240 | 2022-09-30 | 2023-01-26 |
| Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS) Yiqihuayu Decotion - Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Ying Gao | 15 | 2022-09-25 | 2022-09-29 |
| A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke XY03-EA, XY03-EA Placebo - Acute Ischemic Stroke | Phase 2 | Unknown | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 420 | 2022-09-24 | 2023-06-22 |
| Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE Riociguat, Propylthiouracil, Perphenazine - Ischemic Stroke, Acute | Phase 2 | Unknown | Maastricht University | 28 | 2022-09-05 | 2023-10-19 |
| Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction Carbocaine Injectable Product - Ischemic Stroke | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 38 | 2022-06-22 | 2024-01-26 |
Showing 20 of 68. Sign in to see all of them.
Stroke (20) · Cerebrovascular Disorders (5) · Hemorrhagic Stroke (3) · Hypothermia (3) · Cerebral Infarction (2) · Cerebral Palsy (2) · Angina, Stable (1) · Atherosclerosis (1) · Atrial Fibrillation (1) · Brain Diseases (1) · Brain Infarction (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Hemorrhage (1)
Vascular Diseases (68) · Brain Diseases (67) · Cardiovascular Diseases (67) · Central Nervous System Diseases (67) · Nervous System Diseases (67) · Cerebrovascular Disorders (63) · Stroke (48) · Pathological Conditions, Signs and Symptoms (13) · Pathologic Processes (9) · Signs and Symptoms (5) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Body Temperature Changes (3) · Brain Ischemia (3) · Heart Diseases (3)
Aspirin (9) · Sodium Chloride (5) · Tissue Plasminogen Activator (4) · Clopidogrel (3) · Tirofiban (3) · Atorvastatin (2) · Exenatide (2) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (2) · Ringer's Solution (2) · Rivaroxaban (2) · Antihypertensive Agents (1) · Biguanides (1) · Bromocriptine (1) · Cardiovascular Agents (1) · Ceftriaxone (1)
Beijing Tiantan Hospital (6) · Capital Medical University (4) · Xijing Hospital (4) · University Hospital Heidelberg (3) · Fudan University (2) · RenJi Hospital (2) · Shanghai Yueyang Integrated Medicine Hospital (2) · University College Dublin (2) · Aldagen (1) · Angde Biotech Pharmaceutical Co., Ltd. (1) · Assistance Publique - Hôpitaux de Paris (1) · Baylor College of Medicine (1) · Biocells (Beijing) Biotech Co.,Ltd (1) · China Medical University Hospital (1) · Christina Kruuse (1)
China (29) · Germany (6) · South Korea (4) · United States (4) · Ireland (2) · Israel (2) · Australia (1) · Austria (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Indonesia (1) · Iran (1)
Sven Poli, Dr. med. (3) · Gang Zhao, M.D. (2) · Yilong Wang, PhD，MD (2) · Adam Kirton, MD MSc FRCPC (1) · Afshin Borhani Haghighi, Associate professor (1) · Alejandro Rabinstein, MD (1) · Andrei V. Alexandrov, MD (1) · Christina R Kruuse, MD,PhD (1) · Christopher Bladin (1) · Erik Popp, PD Dr. med. (1) · Farnia Feiz, medical student (1) · Gang Li, Doctor (1) · Gang Zhao, Doctor (1) · Gang Zhao, MD (1)
PMID 38648030, PMID 16282547, PMID 16336965, PMID 16574919, PMID 18468545, PMID 19233036, PMID 19570514, PMID 19834014, PMID 20075087, PMID 20185783, PMID 20204386, PMID 20651267, PMID 20966420, PMID 22435369, PMID 23040716, PMID 23197640, PMID 23370205, PMID 23418571, PMID 23941576, PMID 24354519, PMID 24610327, PMID 25530442, PMID 25671797, PMID 25726502, PMID 26458895, PMID 26871851, PMID 26898852, PMID 27029628, PMID 27733282, PMID 28082671, PMID 28095900, PMID 28612680, PMID 28780236, PMID 28950419, PMID 29016744, PMID 29127270, PMID 29232823, PMID 29371333, PMID 29444972, PMID 29446769, PMID 29573529, PMID 29601945, PMID 29694815, PMID 29720439, PMID 30005644, PMID 30355104, PMID 30586746, PMID 31236801, PMID 31248555, PMID 31263257
2016 (1), 2018 (1), 2019 (1)